AUDRA EASON: Open Payments
NPI 1174788970 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$895 in 27 payments from 8 companies in 2025. Trend: 2023 $598 · 2024 $916 · 2025 $895
Food & beverage: $895
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $299 |
| REVANCE THERAPEUTICS, INC. | 3 | $177 |
| MERZ NORTH AMERICA, INC. | 3 | $167 |
| Galderma Laboratories, L.P. | 4 | $165 |
| SPR Therapeutics, Inc | 1 | $26 |
| Saluda Medical Americas, Inc. | 1 | $23 |
| Averitas Pharma Inc. | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
Products named: DAXXIFY, Xeomin, BOTOX, SPRINT PNS System, Evoke, QUTENZA, RELISTOR.
Industry payments across AL — which companies pay providers there.
